Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 401.85
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Everest Organics Ltd. is a pharmaceutical company, which engages in the manufacture of bulk drugs. The firm's products include Omeprazole, Ciprofloxacin, Dichloroflurobenzene and Benzimadizole It also manufactures and exports active pharmaceutical ingredients and its intermediates in India; as well as supplies its products to formulation companies worldwide. The company was founded on February 19, 1993...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITD.
Data is available to registered users only
Buy
Sell